COMP <GO>

BTTC vs CELZ // EV/EBITDA & P/E VALUATION

Black Titan Corporation (NASDAQ) VS. Creative Medical Technology Holdings Inc. (NASDAQ) • 15-METRIC TALLY: BTTC 2 — CELZ 1

■ METRIC PARITY

LAST: $0.35 (+4.23%) • MKT CAP: $5.3M

valuation

—

LAST: $0.68 (-5.78%) • MKT CAP: $5.2M

valuation

—

15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BTTC VS. CELZ) EMERALD CELL = QUANTITATIVE EDGE

INSTITUTIONAL METRIC	BTTC	CELZ	SPREAD (A - B)	ADVANTAGE	DEDICATED URL
Gross Profit Margin	—	63.40%	—	TIE	/gross-margins <GO>
Return on Invested Capital (ROIC)	—	-35.00%	—	TIE	/roic <GO>
EV/EBITDA & P/E Valuation ACTIVE	—	—	—	TIE	/valuation <GO>
Free Cash Flow Yield	-2.73%	—	—	TIE	/fcf-yield <GO>
Operating Margin	—	-60.00%	—	TIE	/operating-margins <GO>
Net Profit Margin	—	-60.00%	—	TIE	/net-margins <GO>
Revenue Growth (YoY)	—	-45.50%	—	TIE	/revenue-growth <GO>
Dividend Yield & FCF Payout Safety	0.00%	0.00%	0.00	TIE	/dividend-safety <GO>
Altman Z-Score & Debt/Equity	—	0.20	—	TIE	/balance-sheet <GO>
Piotroski F-Score Quality	1/9	3/9	-2.00	CELZ	/piotroski-score <GO>
Options Implied Move & Put/Call Skew	—	—	—	TIE	/options-implied-move <GO>
RSI-14 & 200D SMA Momentum	36.3	31.7	+4.57	BTTC	/rsi-technicals <GO>
10Y Yield & FRED Macro Beta	—	—	—	TIE	/macro-sensitivity <GO>
Forward P/E Multiple	—	—	—	TIE	/forward-pe <GO>
Enterprise Scale & Market Cap	$5.3M	$5.2M	$101.1K	BTTC	/market-cap <GO>

5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY

FISCAL YEAR	BTTC REV	CELZ REV	BTTC GROSS %	CELZ GROSS %	BTTC FCF	CELZ FCF
FY 2025	$0	$6.0K	—	63.4%	-$143.2K	-$5.9M
FY 2024	—	$11.0K	—	60.0%	—	-$5.3M
FY 2023	—	$9.0K	—	—	—	-$8.0M

FRED MACRO REGIME CORRELATION COMPARISON PEARSON r

BTTC // BETA —

CELZ // BETA —